Director, Interventional Cardiology
Director, Tissue Engineering Lab
Instrumental in formation of SynCardia Systems, Inc., maker of the CardioWest Temporary Total Artificial Heart (TAH-t)
1501 N. Campbell Ave
Tucson, AZ 85724
Fax: (520) 626-7625
PO Box: 245037
University of Cincinnati College of Medicine, 1981
In July 2009 Dr Slepian was appointed chairman of the Science Advisory Board for MicroMed Cardiovascular, manufacturer of the HeartAssist 5™ ventricular assist device.
The CardioWest (trademarked) TAH-t completely replaces the blood-pumping function of the diseased heart. For patients with end-stage congestive heart failure at imminent risk of death, this device has proven to be a life-saver, allowing them to be "bridged" and supported until a human heart transplant can be performed.
He is recognized for his research and development of novel therapeutics. These include the use of polymeric biomaterials as tissue supports, barriers or means of local drug delivery in tubular organs or organ components, biodegradable stents, drug-eluting stents and the TAH.